Qing-Sheng Mi

Dr. Qing-Sheng Mi is a cancer research scientist affiliated with the Henry Ford Cancer Institute and Henry Ford Hospital in Detroit, Michigan. His academic work focuses on immunology and dermatology research, with specializations in tumor immunology, microRNA biology, and inflammatory skin disease mechanisms.

• Education: PhD from China Medical University (2002), BS from Taishan Medical University (1985)
• Specialties: Cancer research, immunotherapy, and dermatology

Current research explores iNKT cell anti-tumor mechanisms, sex-based immunological differences in hidradenitis suppurativa, and dendritic cell-based immunotherapy approaches. His work spans from basic genetic research to clinical applications, with emphasis on biomarker discovery and novel therapeutic strategies.

Key publication trends show focus on immuno-oncology (2018-2025), dendritic cell therapies (2020-2022), and metabolic disorder models (2008-2015). Recent articles emphasize single-cell sequencing techniques and precision medicine applications.